DE69821970D1 - Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE - Google Patents

Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE

Info

Publication number
DE69821970D1
DE69821970D1 DE69821970T DE69821970T DE69821970D1 DE 69821970 D1 DE69821970 D1 DE 69821970D1 DE 69821970 T DE69821970 T DE 69821970T DE 69821970 T DE69821970 T DE 69821970T DE 69821970 D1 DE69821970 D1 DE 69821970D1
Authority
DE
Germany
Prior art keywords
citicoline
multiple sclerosis
treating multiple
disease
als
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69821970T
Other languages
English (en)
Other versions
DE69821970T2 (de
Inventor
Bobby W Sandage Jr
L Cooper
W Locke
Takashi Kiyoizumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Interneuron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interneuron Pharmaceuticals Inc filed Critical Interneuron Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69821970D1 publication Critical patent/DE69821970D1/de
Publication of DE69821970T2 publication Critical patent/DE69821970T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
  • Control Of Stepping Motors (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
DE69821970T 1997-11-26 1998-11-24 Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE Expired - Lifetime DE69821970T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6655697P 1997-11-26 1997-11-26
US66556P 1997-11-26
US6701797P 1997-12-01 1997-12-01
US67017P 1997-12-01
US12977898A 1998-08-06 1998-08-06
US129778 1998-08-06
PCT/US1998/025051 WO1999026633A1 (en) 1997-11-26 1998-11-24 Citicoline to treat motor neuron diseases and demyelinating diseases

Publications (2)

Publication Number Publication Date
DE69821970D1 true DE69821970D1 (de) 2004-04-01
DE69821970T2 DE69821970T2 (de) 2004-12-16

Family

ID=27370993

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821970T Expired - Lifetime DE69821970T2 (de) 1997-11-26 1998-11-24 Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE

Country Status (10)

Country Link
EP (1) EP1032402B1 (de)
JP (1) JP2001523724A (de)
AT (1) ATE260108T1 (de)
AU (1) AU1601499A (de)
CA (1) CA2311422A1 (de)
DE (1) DE69821970T2 (de)
DK (1) DK1032402T3 (de)
ES (1) ES2216334T3 (de)
PT (1) PT1032402E (de)
WO (1) WO1999026633A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1053749A4 (de) * 1998-02-03 2003-01-15 Senju Pharma Co Vorbeuge- und heilmittel für neurodegenerative erkrankungen
WO2004006940A1 (ja) * 2002-07-11 2004-01-22 Yamasa Corporation 薬剤誘発性神経障害用医薬組成物
CN111263636A (zh) 2017-09-08 2020-06-09 Tx医生公司 硫酸葡聚糖的新用途
US20200215149A1 (en) * 2019-01-08 2020-07-09 Christopher David Thompson N-Phenylacetyl-L-prolylglycine ethyl ester compositions and methods for using the same
RU2759654C1 (ru) * 2020-12-14 2021-11-16 Частное учреждение образовательная организация высшего образования "Медицинский университет "Реавиз" Способ интраоперационной профилактики гипоксии головного мозга во время проведения каротидной эндартерэктомии
WO2023190797A1 (ja) * 2022-03-30 2023-10-05 味の素株式会社 筋質改善用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
DE3400276A1 (de) * 1984-01-05 1985-07-18 Ferrer Internacional S.A., Barcelona Verwendung von cdp-cholin zur behandlung von neurologischen stoerungen
CN1036119C (zh) * 1995-06-28 1997-10-15 北京格特生物工程科技开发公司 用于治疗视神经萎缩药物的复方制剂

Also Published As

Publication number Publication date
WO1999026633A1 (en) 1999-06-03
DE69821970T2 (de) 2004-12-16
PT1032402E (pt) 2004-06-30
ATE260108T1 (de) 2004-03-15
CA2311422A1 (en) 1999-06-03
JP2001523724A (ja) 2001-11-27
ES2216334T3 (es) 2004-10-16
EP1032402A1 (de) 2000-09-06
EP1032402B1 (de) 2004-02-25
DK1032402T3 (da) 2004-05-10
AU1601499A (en) 1999-06-15

Similar Documents

Publication Publication Date Title
DE69533040D1 (de) Medikamente zur vorbeugung oder behandlung von vaskulären hämorrhagien
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
ATE319474T1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
DE69617469D1 (de) Behandlung von multipler sklerose
KR960702318A (ko) 근육 질병 및 장애의 치료방법
ATE154758T1 (de) Levobupivacain nützlich zur behandlung von chronischen schmerzen
ATE321548T1 (de) Verwendung von statin zur behandlung von hauterkrankungen
BR9808100A (pt) Utilização de amandantina para tratamento de hepatite c.
PT994743E (pt) Tratamento de disturbios inflamatorios do intestino ou da bexiga
DE69820053D1 (de) Stör-notokord zur verminderung der symptome / behandlung von arthritis
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
DE69821970D1 (de) Verwendung von CITICOLINE ZUR BEHANDLUNG VON MULTIPLER SKLEROSE
ATE217191T1 (de) Verwendung von phanquinon zur behandlung von alzheimer's krankheit
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
ATE213163T1 (de) Verfahren zur behandlung von motorischen defiziten
MXPA00010254A (es) Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
ATE462717T1 (de) Verfahren und zusammensetzungen für die diagnose und die behandlung von krankheiten, die mit eisenüberschuss oder eisenmangel assoziiert sind
WO1996020950A3 (en) Compositions and methods for treating rheumatoid arthritis
ATE251462T1 (de) Verfahren zur behandlung von narbengewebe
RU2038102C1 (ru) Способ лечения вибрационной болезни
RU94035038A (ru) Способ получения препарата для лечения координаторных нарушений из мозжечково-стволового отдела головного мозга
DE69307702T2 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
RU2045291C1 (ru) Способ лечения полиневропатий
RU2147218C1 (ru) Способ лечения вибрационной болезни
EA199800941A1 (ru) Терапевтические средства, содержащие кислородные анион-радикалы и/или продукты их последующего превращения и расщепления, и их применение для лечения болезни паркинсона

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FERRER INTERNACIONAL S.A., BARCELONA, ES

8328 Change in the person/name/address of the agent

Representative=s name: REITSTOETTER, KINZEBACH & PARTNER (GBR), 81679 MUENCHEN